CO6400235A2 - Tensiactivos reconstituidos que tienen propiedades mejoradas - Google Patents

Tensiactivos reconstituidos que tienen propiedades mejoradas

Info

Publication number
CO6400235A2
CO6400235A2 CO09036247A CO09036247A CO6400235A2 CO 6400235 A2 CO6400235 A2 CO 6400235A2 CO 09036247 A CO09036247 A CO 09036247A CO 09036247 A CO09036247 A CO 09036247A CO 6400235 A2 CO6400235 A2 CO 6400235A2
Authority
CO
Colombia
Prior art keywords
reconstituted
tensitives
improved properties
polypeptide
analog
Prior art date
Application number
CO09036247A
Other languages
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6400235(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of CO6400235A2 publication Critical patent/CO6400235A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fire-Extinguishing Compositions (AREA)

Abstract

La presente invención se refiere a un tensioactivoreconstituido que comprende un portador lípido, un polipéptido análogo de la proteína tensioactiva nativa SP-C, y un análogo de polipéptido de la proteína tensioactiva nativa SP-B. La invención también se dirige a las composiciones farmacéuticas del mismo y a su uso para eltratamiento de profilaxis de RDS y otros trastornos respiratorios.
CO09036247A 2006-10-13 2009-04-08 Tensiactivos reconstituidos que tienen propiedades mejoradas CO6400235A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
CO6400235A2 true CO6400235A2 (es) 2012-03-15

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09036247A CO6400235A2 (es) 2006-10-13 2009-04-08 Tensiactivos reconstituidos que tienen propiedades mejoradas

Country Status (36)

Country Link
US (2) US8183210B2 (es)
EP (1) EP2078038B1 (es)
JP (2) JP5405307B2 (es)
KR (1) KR101328851B1 (es)
CN (2) CN103169947B (es)
AR (2) AR063263A1 (es)
AU (1) AU2007306075B2 (es)
BR (1) BRPI0715317B1 (es)
CA (1) CA2666344C (es)
CL (1) CL2007002931A1 (es)
CO (1) CO6400235A2 (es)
CY (1) CY1114716T1 (es)
DK (1) DK2078038T3 (es)
EA (1) EA015802B1 (es)
ES (1) ES2438727T3 (es)
GE (1) GEP20125531B (es)
HK (2) HK1134497A1 (es)
HR (1) HRP20140052T1 (es)
IL (1) IL198075A (es)
JO (1) JO2963B1 (es)
MA (1) MA31062B1 (es)
ME (2) MEP12109A (es)
MX (1) MX343064B (es)
MY (1) MY148127A (es)
NO (1) NO342038B1 (es)
NZ (1) NZ576189A (es)
PE (1) PE20081184A1 (es)
PL (1) PL2078038T3 (es)
PT (1) PT2078038E (es)
RS (1) RS53172B (es)
SI (1) SI2078038T1 (es)
TN (1) TN2009000099A1 (es)
TW (1) TWI388333B (es)
UA (1) UA94477C2 (es)
WO (1) WO2008044109A1 (es)
ZA (1) ZA200902481B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP2812018B1 (en) 2012-02-09 2018-12-05 University Of Rochester Novel sp-b&sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
ES2644317T3 (es) * 2012-11-21 2017-11-28 Chiesi Farmaceutici S.P.A. Tensioactivos pulmonares reconstituidos
EP3393489B1 (en) * 2015-12-17 2021-09-01 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
EP3452041A4 (en) 2016-03-07 2020-11-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center COMPOSITIONS AND METHOD OF ADMINISTRATION OF PPAR AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS
KR102395835B1 (ko) * 2016-08-24 2022-05-10 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
US20100004173A1 (en) 2010-01-07
JP2010505937A (ja) 2010-02-25
UA94477C2 (ru) 2011-05-10
KR101328851B1 (ko) 2013-11-14
AU2007306075A1 (en) 2008-04-17
US20130079275A1 (en) 2013-03-28
JP2013241449A (ja) 2013-12-05
MEP12109A (en) 2011-12-20
KR20090083892A (ko) 2009-08-04
US8183210B2 (en) 2012-05-22
NZ576189A (en) 2011-09-30
CL2007002931A1 (es) 2008-03-24
MY148127A (en) 2013-02-28
CN103169947B (zh) 2014-10-29
CY1114716T1 (el) 2016-10-05
HK1134497A1 (en) 2010-04-30
GEP20125531B (en) 2012-05-25
ES2438727T3 (es) 2014-01-20
BRPI0715317B1 (pt) 2021-10-05
SI2078038T1 (sl) 2014-02-28
AU2007306075B2 (en) 2012-08-09
AR063263A1 (es) 2009-01-14
ME02326B (me) 2016-06-20
TWI388333B (zh) 2013-03-11
US9238058B2 (en) 2016-01-19
MX343064B (es) 2016-10-24
CN103169947A (zh) 2013-06-26
NO20091441L (no) 2009-06-23
PE20081184A1 (es) 2008-09-26
PT2078038E (pt) 2013-12-12
AR113422A2 (es) 2020-04-29
BRPI0715317A2 (pt) 2013-07-09
CN101522711A (zh) 2009-09-02
HK1185274A1 (en) 2014-02-14
IL198075A (en) 2016-04-21
JO2963B1 (en) 2016-03-15
RS53172B (en) 2014-06-30
PL2078038T3 (pl) 2014-05-30
CA2666344C (en) 2017-04-18
DK2078038T3 (da) 2013-12-02
TN2009000099A1 (en) 2010-08-19
EA015802B1 (ru) 2011-12-30
TW200824705A (en) 2008-06-16
IL198075A0 (en) 2011-08-01
CN101522711B (zh) 2013-11-13
HRP20140052T1 (hr) 2014-02-28
NO342038B1 (no) 2018-03-19
MX2009003638A (es) 2009-04-22
CA2666344A1 (en) 2008-04-17
EP2078038A1 (en) 2009-07-15
MA31062B1 (fr) 2010-01-04
EP2078038B1 (en) 2013-11-20
JP5405307B2 (ja) 2014-02-05
EA200900373A1 (ru) 2009-10-30
WO2008044109A1 (en) 2008-04-17
ZA200902481B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
CO6400235A2 (es) Tensiactivos reconstituidos que tienen propiedades mejoradas
UA103526C2 (ru) Воспроизведенный сурфактант, который содержит аналоги белков естественных сурфактантов sp-b и sp-c
EA200901459A1 (ru) Реконструированные поверхностно-активные вещества, имеющие улучшенные свойства
ECSP14030742A (es) Proteínas del factor 21 de crecimiento del fibroblasto
CO6640254A2 (es) Método para preparar anticuerpos con propiedades mejoradas
ECSP19072294A (es) Composición farmacéutica que comprende selexipag
BR112015009486A2 (pt) surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
BR112017013696A2 (pt) peptídeos e seu uso no tratamento de pele
BRPI0813619A2 (pt) peptídeos surfactantes pulmonares sintéticos
BR112021020883A2 (pt) Formas sólidas de um inibidor de glyt1
CL2011002893A1 (es) Peptido derivado del factor viii; composicion que lo comprende; uso para aumentar la tolerancia a factor viii en individuos que padecen o estan en riesgo de padecer hemofilia a o hemofilia adquirida.
AR115617A1 (es) Composición cosmética para el tratamiento de las fibras de queratina
RS20170169A1 (sr) Poboljšana rekonstituisana kompozicija sufraktanta koja sadrži analoge sufraktanta proteina b (sp-b) i surfaktanta proteina c (sp-c)
CL2022001035A1 (es) Composiciones y métodos para minimizar la pérdida de proteínas a concentraciones de proteínas bajas
CL2020002398A1 (es) Inhibidores de secreción de proteínas basados en triazaciclododecansulfonamida ("tcd")

Legal Events

Date Code Title Description
FC Application refused